Pfizer is an API and finished-dose manufacturer based in Switzerland. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its filings concentrate with INHRR (VE), SWISSMEDIC (CH) and FAMHP (BE). Its GMP standing is certified by HSA (SG). Its most recent recorded inspection, by US FDA, closed on 20 August 2019 as NAI. Customs aggregates show $649K of exports covering 1,975 molecules to 5 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Louvain-La-Neuve, Belgium | Not on file |
| Zürich, Switzerland | Not on file |
| EL JADIDA, Morocco | Not on file |
| Chesterfield, United States | 1940118 |
| Molecule | Regulators | Docs |
|---|---|---|
| Heparin Sodium | US FDA | 1 |
| Prasterone | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| INHRR (VE) | 296 | None |
| SWISSMEDIC (CH) | 287 | None |
| FAMHP (BE) | 186 | None |
| DKMA (DK) | 178 | None |
| HSA (SG) | 170 | 4 |
| DMP (NO) | 126 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $154K | 5 |
| 2025 | Not reported | $649K | 5 |
| 2024 | Not reported | $641K | 4 |
| 2023 | Not reported | $829K | 5 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Pfizer comes back tiered against every other supplier able to file there.
Start for free